Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Immunology
Impact-faktor: 1.352 5-jähriger Impact-Faktor: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Druckformat: 1040-8401
ISSN Online: 2162-6472

Volumes:
Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v28.i2.10
pages 95-107

Pathogen-Associated Molecular Pattern in Cancer Immunotherapy

Uwe Hobohm
University of Applied Sciences, Bioinformatics, Wiesenstrasse 14, D-35390 Giessen, Germany
John L. Stanford
Centre for Infectious Disease and International Health, Windeyer Institute for Medical Sciences, University College London, 46 Cleveland Street, London W1T 4JF, UK
John M. Grange
Centre for Infectious Disease and International Health, Windeyer Institute for Medical Sciences, University College London, 46 Cleveland Street, London W1T 4JF, UK

ABSTRAKT

Observations from different research frontiers—epidemiological data, case studies on spontaneous regressions from cancer, clinical studies, tumor immunology—indicate that exposure by vaccination or infection to pathogen-associated molecular patterns (PAMP) can have beneficial effects on neoplastic diseases, both prophylactically and therapeutically. These effects have not yet been harnessed to their full extent for the prophylaxis and therapy of cancer. Here, we summarize clinical, epidemiological, and experimental data and discuss the role of PAMP in cancer therapy.